Amylin
Authors:
- Liza Kirsty PhillipsLPLiza Kirsty Phillips
- Michael HorowitzMHMichael Horowitz
- 1 April 2006
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 13 (2) , 191-198
Abstract
Phillips, Liza Kirsty; Horowitz, MichaeKeywords
This publication has 62 references indexed in Scilit:
- Amylin Agonists: A Novel Approach in the Treatment of DiabetesDiabetes, 2004
- Amylin receptors: molecular composition and pharmacologyBiochemical Society Transactions, 2004
- Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2004
- Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?Diabetologia, 2004
- Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic ControlCurrent Pharmaceutical Design, 2001
- Islet Amyloid and Type 2 Diabetes MellitusNew England Journal of Medicine, 2000
- Processing of synthetic pro‐islet amyloid polypeptide (proIAPP) ‘amylin’ by recombinant prohormone convertase enzymes, PC2 and PC3, in vitroEuropean Journal of Biochemistry, 2000
- Amylin Compared with Calcitonin Gene-Related Peptide: Structure, Biology, and Relevance to Metabolic DiseaseEndocrine Reviews, 1994
- Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.Proceedings of the National Academy of Sciences, 1987
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986